Analyst Upgrades: Activision Blizzard, First Solar, Teva
Teva Stock Slips on Back of Weak 2019 Outlook; Analysts Weigh In
October 8th Options Now Available For Teva Pharmaceutical Industries | Nasdaq
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock
Teva, Bioeq Partner to Sell Lucentis Biosimilar
Valeant on the Street: Analyst Recommendations in December 2017
Teva Faces Rocky Path to Recovery After Debt | Fortune